AstraZeneca is putting two buildings on the real estate market.The company plans to eventually split its south campus from the north campus in north Wilmington, according to the company.
Specific site changes have not yet determined, the company stated.
Going on the market are two buildings – a four-story, 203,602-square-foot structure and a three-story, 153,949-square-foot structure. The buildings, built in 2002, contain a dining facility, hair salon, fitness center, conference and training center as part of the complex. The company first announced plans to consolidate its campuses in March.
Recently, it was reported that the former Rollins building, also owned by AstraZeneca, was sold to a company owned by Applied Bank owner Rocco Abessinio. Applied has operations in Delaware County, Pa and a full-service bank in Delaware.
Parking is available for 2,259 vehicles between a garage and surface lot. A tennis and basketball courts are part of the package. The 58-acre parcel has been approved for an additional 832,000 square feet of office space along with a new parking structure that could add 1,921 spaces. Solar installations on the South campus are included in the sale.
The buildings were constructed as part of the consolidation of the company after Swedish-based Astra and United Kingdom-based Zeneca merged and consolidated Delaware Valley operations at the site.
The state of Delaware offered an incentive package to draw the companies that included major roadwork in the area.
Such incentives have widely criticized on the national stage, but Delaware normally gains back the money fairly rapidly in additional income tax revenues.
DelawareOnLine.com reported the real estate firm of Jones Lang LaSalle is the listing broker. The real estate company did not respond to an e-mail request for comment.
AstraZeneca plans to reduce employment at the north Wilmington site by 1,200 and shift a portion of those jobs to its Medimmune subsidiary in Maryland.
